Table 2.
Study | S (/4) | C (/2) | O (/3) | NOS score | Confounding factor | Mortality (B vs Ct) |
---|---|---|---|---|---|---|
Stebbing [10] | 4 | 2 | 2 | 8 | – | 1/37 vs 4/37 |
Bronte [15] | 4 | 2 | 2 | 8 | + | 1/20 vs 25/56 |
Hasan [17] | 4 | 1 | 1 | 6 | – | 4/122 vs 7/116 |
Hasan [18] | 4 | 1 | 1 | 6 | – | 1/21 vs 1/17 |
Rodriguez-Garcia [19] | 4 | 1 | 2 | 7 | + | 5/117 vs 11/270 |
Abizanda [26] | 4 | 2 | 1 | 7 | – | 22/164 vs 43/164 |
Cantini [12] | 4 | 2 | 3 | 9 | + | 0/113 vs 5/78 |
Rosas [27] | 4 | 2 | 2 | 8 | – | 2/12 vs 6/17 |
Perez-Alba [20] | 4 | 1 | 2 | 7 | + | 25/123 vs 30/74 |
García-García [23] | 4 | 1 | 2 | 7 | + | 36/217 vs 22/125 |
Falcone [31] | 4 | 2 | 1 | 7 | + | 5/21 vs 3/21 |
S = selection; C = comparability; O = outcomes; + = present; - = absent; vs = versus; B = baricitinib; Ct = control.